Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: chemistry – Page 271

Water is the most abundant yet least understood liquid in nature. It exhibits many strange behaviors that scientists still struggle to explain. While most liquids get denser as they get colder, water is most dense at 39 degrees Fahrenheit, just above its freezing point. This is why ice floats to the top of a drinking glass and lakes freeze from the surface down, allowing marine life to survive cold winters. Water also has an unusually high surface tension, allowing insects to walk on its surface, and a large capacity to store heat, keeping ocean temperatures stable.

Now, a team that includes researchers from the Department of Energy’s SLAC National Accelerator Laboratory, Stanford University and Stockholm University in Sweden have made the first direct observation of how in water tug and push neighboring water molecules when they are excited with laser light. Their results, published in Nature today, reveal effects that could underpin key aspects of the microscopic origin of water’s strange properties and could lead to a better understanding of how water helps proteins function in living organisms.

“Although this so-called nuclear quantum effect has been hypothesized to be at the heart of many of water’s strange properties, this experiment marks the first time it was ever observed directly,” said study collaborator Anders Nilsson, a professor of chemical physics at Stockholm University. “The question is if this quantum effect could be the missing link in theoretical models describing the anomalous properties of water.”

Read more | >

Pico technology is hypothetical future level of technology which will revolutionized the scientist world. This technology is combination of pico and meter with scale of trillionths of a meter (10−12). This atomic and subatomic range particles reveals extraordinary properties and pave the way for tremendous applications [1].

The way lengths and angles attach together is the main determine of the materials properties. Alterable or reversible bonds distortions at pico-meter scale which changes the electronic conformation causes multiple properties for materials.

On the other hand, pico-scale particles changes the material properties by converting energy state of electrons within an atom. Physical and chemical properties of systems such as melting point, fluorescence, electrical conductivity, magnetic permeability, and chemical reactivity changes basically at pico-scale due to quantum effects of materials [2]. Moreover, surface energy of atoms increases by alternation of electron distribution and therefore, enhances protein and molecules adsorption on to materials. This privileges will resulting in tracing proteins, DNA and molecules and labeling them for various purpose.

Read more | >

Lipids are abundant in the brain, where they are found not just in the cell membranes of neurons, whose properties they modulate, but also in the so-called myelin sheaths insulating axons — the brain’s ‘wiring.’ The brain is therefore a surprisingly ‘fat’ organ — in fact, it is nearly 60% fat, the study’s first author, Anna Tkachev from Skoltech, said.

Summary: Prozac reduced polyunsaturated fatty acid lipid concentrations in the brains of juvenile macaque monkeys.

Source: Skoltech

Skoltech researchers and their colleagues from Russia, Germany, and the U.S. have found Prozac to reduce lipid concentrations in juvenile macaques who received the antidepressant for two years, compared to a control group of untreated animals.

While none of the monkeys in the study were depressed, the findings still offer a plausible biochemical explanation for the drug’s side effects, particularly in young patients. The paper was published in the International Journal of Molecular Sciences.

Read more | >

Circa 2014

Scientists in a lab used a powerful laser to re-create what might have been the original spark of life on Earth.

The researchers zapped clay and a chemical soup with the laser to simulate the energy of a speeding asteroid smashing into the planet. They ended up creating what can be considered crucial pieces of the building blocks of .

The findings do not prove that this is how life started on Earth about 4 billion years ago, and some scientists were unimpressed with the results. But the experiment does bolster the long-held theory.

Read more | >

If you think at all about liquid crystals, you probably think of display technology. However, researchers have worked out a way to use an ink-jet-like process to 3D print iridescent colors using a liquid crystal elastomer. The process can mimic iridescent coloring found in nature and may have applications in things as diverse as antitheft tags, art objects, or materials with very special optical properties.

For example, one item created by the team is an arrow that only appears totally green when viewed from a certain angle. The optical properties depend on the thickness of the material which, being crystalline, self-organizes. Controlling the speed of deposition changes the thickness of the material which allows the printer to tune its optical properties.

The ink doesn’t sound too exotic to create, although the chemicals in it are an alphabet soup of unpronounceable organic compounds. At least they appeared available if you know where to shop for exotic chemicals.

Read more | >

Advancing the well-being of animals, people and the planet — aaron schacht — executive vice president, innovation, regulatory & business development, elanco.

Aaron Schacht is Executive Vice President: Innovation, Regulatory + Business Development at Elanco (https://www.elanco.com/), an American pharmaceutical company which produces medicines and vaccinations for pets and livestock, and which until 2,019 was a subsidiary of Eli Lilly and Company.

Prior to this, Mr. Schacht held a role of Global Brand Development Leader – Pain in Lilly Biomedicines. He was the global leader for product development and commercialization activities for Lilly’s novel CGRP neutralizing antibody – a new potential treatment for prevention of Migraine and Cluster Headache.

In 2,012 Mr. Schacht joined Lilly Biomedicines as Senior Advisor – Strategy & Business Development for Lilly BioMedicines. His responsibilities included oversight of Therapeutic Strategy development, R&D Portfolio Management, and Business Development for Lilly BioMedicines – Lilly’s largest business unit. Past roles included serving as Executive Director, Global External R&D, at Eli Lilly and Company, where he was responsible for implementation of strategies which aim to leverage novel approaches to external partnerships to augment Lilly’s access to pharmaceutical innovation as well as Executive Director of LRL (Lilly Research Labs) Strategy, Portfolio Management and Project Management where he was responsible for strategic planning, R&D portfolio and project management. Prior to these roles, he was Director, Innovation Center in the eLilly organization where he focused on the exploration, incubation and implementation of new business models and capabilities relevant to the strategic evolution of the pharmaceutical industry.

In 2,002 during a short leave from Lilly, Mr. Schacht was co-founder, President and CEO of Artesian Therapeutics, a Gaithersburg, MD cardiovascular drug discovery start-up.

Continue reading “Aaron Schacht — EVP, Innovation, Regulatory + BD, Elanco — Well-Being Of Animals, People And Planet” | >

Since the early days of the COVID pandemic, scientists have aggressively pursued the secrets of the mechanisms that allow severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter and infect healthy human cells.

Early in the pandemic, University of California San Diego’s Rommie Amaro, a computational biophysical chemist, helped develop a detailed visualization of the SARS-CoV-2 spike protein that efficiently latches onto our cell receptors.

Now, Amaro and her research colleagues from UC San Diego, University of Pittsburgh, University of Texas at Austin, Columbia University and University of Wisconsin-Milwaukee have discovered how glycans–molecules that make up a sugary residue around the edges of the spike protein–act as infection gateways.

Published August 19 in the journal Nature Chemistry, a research study led by Amaro, co-senior author Lillian Chong at the University of Pittsburgh, first author and UC San Diego graduate student Terra Sztain and co-first author and UC San Diego postdoctoral scholar Surl-Hee Ahn, describes the discovery of glycan “gates” that open to allow SARS-CoV-2 entry.

Read more | >

I am pleased to announce that my lead-author review paper has been published in ACS Nano! If you are interested in learning about the convergence of synthetic biology and adenoviral gene therapy, I encourage you to check out my paper.

If you cannot access the full text, I have also posted a local copy at the following link: https://logancollinsblog.files.wordpress.com/2021/08/synthet…s-2021.pdf.

#ACS #ACSNano #SyntheticBiology #GeneTherapy #Biology #Biotech #Science #Biotechnology #Nanotechnology #Adenovirus #Engineering #Virology

Synthetic biology centers on the design and modular assembly of biological parts so as to construct artificial biological systems. Over the past decade, synthetic biology has blossomed into a highly productive field, yielding advances in diverse areas such as neuroscience, cell-based therapies, and chemical manufacturing. Similarly, the field of gene therapy has made enormous strides both in proof-of-concept studies and in the clinical setting. One viral vector of increasing interest for gene therapy is the adenovirus (Ad). A major part of the Ad’s increasing momentum comes from synthetic biology approaches to Ad engineering. Convergence of gene therapy and synthetic biology has enhanced Ad vectors by mitigating Ad toxicity in vivo, providing precise Ad tropisms, and incorporating genetic circuits to make smart therapies which adapt to environmental stimuli. Synthetic biology engineering of Ad vectors may lead to superior gene delivery and editing platforms which could find applications in a wide range of therapeutic contexts.

Read more | >